BMS-905 is a potent dual inhibitors of TLR7 and TLR8 with good selectivity against TLR9 and other family members. BMS-905 can be used in studies about the treatment of diseases such as psoriasis, arthritis, and lupus.
Molecular Weight:
347.5
Purity:
99.94%
CAS Number:
[2205846-49-5]
Formula:
C23H29N3
Target:
TLR
* VAT and and shipping costs not included. Errors and price changes excepted